Chapter 11. Statins in Atherosclerosis: Role of Immune Regulation

  1. Ronald Ross Watson1,2 and
  2. Douglas F. Larson3
  1. Claire Arnaud and
  2. François Mach

Published Online: 15 APR 2008

DOI: 10.1002/9780470692325.ch11

Immune Dysfunction and Immunotherapy in Heart Disease

Immune Dysfunction and Immunotherapy in Heart Disease

How to Cite

Arnaud, C. and Mach, F. (2007) Statins in Atherosclerosis: Role of Immune Regulation, in Immune Dysfunction and Immunotherapy in Heart Disease (eds R. R. Watson and D. F. Larson), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470692325.ch11

Editor Information

  1. 1

    Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona

  2. 2

    Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA

  3. 3

    Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA

Publication History

  1. Published Online: 15 APR 2008
  2. Published Print: 30 AUG 2007

ISBN Information

Print ISBN: 9781405155687

Online ISBN: 9780470692325

SEARCH

Keywords:

  • artherosclerosis;
  • immune regulation;
  • lipid core;
  • reductase;
  • isoorenylation

Summary

This chapter contains section titled:

  • Introduction

  • Clinical evidence of statins pleiotropic effects

  • MHC-II expression

  • Leukocyte adhesion and migration

  • T-cell immune response

  • CD40—CD40L

  • Conclusion

  • References